Literature DB >> 25297014

Therapy of amyotrophic lateral sclerosis remains a challenge.

Leonard H van den Berg1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25297014     DOI： 10.1016/S1474-4422(14)70179-6

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN： 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  3 in total

Review 1.  EAAT2 and the Molecular Signature of Amyotrophic Lateral Sclerosis.

Authors:  Lauren Taylor Rosenblum; Davide Trotti
Journal:  Adv Neurobiol       Date:  2017

Review 2.  UBA1: At the Crossroads of Ubiquitin Homeostasis and Neurodegeneration.

Authors:  Ewout J N Groen; Thomas H Gillingwater
Journal:  Trends Mol Med       Date:  2015-10       Impact factor: 11.951

3.  Perturbations of the Proteome and of Secreted Metabolites in Primary Astrocytes from the hSOD1(G93A) ALS Mouse Model.

Authors:  Roberto Stella; Raphael Severino Bonadio; Stefano Cagnin; Maria Lina Massimino; Alessandro Bertoli; Caterina Peggion
Journal:  Int J Mol Sci       Date:  2021-06-29       Impact factor: 5.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.